CLINICAL_TRIALS
trial_result
· 2018-10-19
Clinical Trial Update: Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer [Phase 2]
Summary
Phase 2 trial update for LY573636-Sodium in patients with metastatic non-small cell lung cancer has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non-Small-Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-10-19